Card Tech Minutes 2013.01.09: Difference between revisions

From IHE Wiki
Jump to navigation Jump to search
Newer edit →
Created page with "== Attendees == * Alan Katz - ACC * Antje Schroeder - Siemens * Barry Brown - Mortara * Chris Melo - Philips * Paul Dow - ACC * Paul Seifert - Agfa * Paul Varghese - Agfa * Tom..."
 
Line 12: Line 12:
== Meeting Notes ==
== Meeting Notes ==


#     How important is multiple-vendor Interoperability to you in cardiology workflow  
# How important is multiple-vendor Interoperability to you in cardiology workflow  
a.      critical – it’s one of the top 5 selection criteria and is a deal-breaker
## critical – it’s one of the top 5 selection criteria and is a deal-breaker
b.      high – it’s very important and always comes up, but not a buy/not-buy dealbreaker
## high – it’s very important and always comes up, but not a buy/not-buy dealbreaker
c.      medium  - it always there and considered
## medium  - it always there and considered
d.      low – it never really comes up  
## low – it never really comes up  
2.      what are key interoperability pain points that you experience today - please specify
# What are key interoperability pain points that you experience today - please specify
a.       
##     
b.     
##     
c.       
##     
3.      What is your role in Cardiology IT purchasing decisions
# What is your role in Cardiology IT purchasing decisions
a.      Decision maker, member of decision making unit
## Decision maker, member of decision making unit
b.      Decision influencer – consulted by decision makers  
## Decision influencer – consulted by decision makers  
c.      None
## None
4.      How important is multiple-vendor Interoperability to you in cardiology IT purchasing decisions  
# How important is multiple-vendor Interoperability to you in cardiology IT purchasing decisions  
a.      critical – it’s one of the top 5 selection criteria and is a deal-breaker
## critical – it’s one of the top 5 selection criteria and is a deal-breaker
b.      high – it’s very important and always comes up, but not a buy/not-buy dealbreaker
## high – it’s very important and always comes up, but not a buy/not-buy dealbreaker
c.      medium  - it always there and considered
## medium  - it always there and considered
d.      low – it never really comes up  
## low – it never really comes up  
5.      Are you aware of IHE (Integrating the Healthcare Enterprise)  
# Are you aware of IHE (Integrating the Healthcare Enterprise)  
a.      ? never heard of it
## ? never heard of it
b.      Somewhat familiar  
## Somewhat familiar  
c.      Very familiar – continually use it in my discussion on cardiology Interoperability
## Very familiar – continually use it in my discussion on cardiology Interoperability
6.        If yes  - describe its role in addressing your interoperability concerns
# If yes  - describe its role in addressing your interoperability concerns
a.      Very Valuable – please mention specific profiles used  
## Very Valuable – please mention specific profiles used  
b.      Not Available – vendors do not have requested profiles or only incomplete support
## Not Available – vendors do not have requested profiles or only incomplete support
                                                              i.      Please illustrate  
###  Please illustrate  
c.      Not fully applicable  - it has gaps which doesn’t address my key concerns – please specify
## Not fully applicable  - it has gaps which doesn’t address my key concerns – please specify
7.      Would you like a follow-up to find out more information?
# Would you like a follow-up to find out more information?
a.      Contact method ( phone/email)  
## Contact method ( phone/email)  
b.      no
## no

Revision as of 02:59, 10 January 2013

Attendees

  • Alan Katz - ACC
  • Antje Schroeder - Siemens
  • Barry Brown - Mortara
  • Chris Melo - Philips
  • Paul Dow - ACC
  • Paul Seifert - Agfa
  • Paul Varghese - Agfa
  • Tom Dolan - Philips

Meeting Notes

  1. How important is multiple-vendor Interoperability to you in cardiology workflow
    1. critical – it’s one of the top 5 selection criteria and is a deal-breaker
    2. high – it’s very important and always comes up, but not a buy/not-buy dealbreaker
    3. medium - it always there and considered
    4. low – it never really comes up
  2. What are key interoperability pain points that you experience today - please specify
  3. What is your role in Cardiology IT purchasing decisions
    1. Decision maker, member of decision making unit
    2. Decision influencer – consulted by decision makers
    3. None
  4. How important is multiple-vendor Interoperability to you in cardiology IT purchasing decisions
    1. critical – it’s one of the top 5 selection criteria and is a deal-breaker
    2. high – it’s very important and always comes up, but not a buy/not-buy dealbreaker
    3. medium - it always there and considered
    4. low – it never really comes up
  5. Are you aware of IHE (Integrating the Healthcare Enterprise)
    1. ? never heard of it
    2. Somewhat familiar
    3. Very familiar – continually use it in my discussion on cardiology Interoperability
  6. If yes - describe its role in addressing your interoperability concerns
    1. Very Valuable – please mention specific profiles used
    2. Not Available – vendors do not have requested profiles or only incomplete support
      1. Please illustrate
    3. Not fully applicable - it has gaps which doesn’t address my key concerns – please specify
  7. Would you like a follow-up to find out more information?
    1. Contact method ( phone/email)
    2. no
Retrieved from "http://wiki.ihe.net/index.php?title=Card_Tech_Minutes_2013.01.09&oldid=65258"